Type 1 Diabetes Clinical Trial
— T-REXOfficial title:
Timing of Resistance Exercise, Glucose Control and Exercise Adaptations in People With Type 1 Diabetes: a Randomised-controlled Trial
The aims of the current study are 1. to compare the effects of acute morning and afternoon resistance exercise on blood glucose levels in people with type 1 diabetes. 2. to compare the effects of morning and afternoon resistance exercise training on cardiometabolic health outcomes in people with type 1 diabetes
Status | Recruiting |
Enrollment | 54 |
Est. completion date | December 31, 2024 |
Est. primary completion date | December 31, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 21 Years to 60 Years |
Eligibility | Inclusion Criteria: - Physician confirmed type 1 diabetes for at least 1 year - Stable insulin therapy for 3 months prior to the study Exclusion Criteria: - BMI of 45 or higher - BP of 160/100mmHg or higher - autonomic neuropathy - severe proliferative retinopathy - joint or limb injuries preventing weight-bearing activity - autonomic neuropathy - severe proliferative retinopathy - any other medical condition that prevents participants from exercising safely. |
Country | Name | City | State |
---|---|---|---|
Kuwait | Dasman Diabetes Institute | Kuwait City |
Lead Sponsor | Collaborator |
---|---|
Dasman Diabetes Institute |
Kuwait,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in muscle strength | Sum of one repetition maximum for the 7 resistance exercise | Change from baseline to 12 weeks | |
Primary | Change in interstitial glucose time in range | Interstitial glucose time in range (3.9-10mmol/L) measured via continuous glucose monitoring | Change from 6 hours before (baseline) to 6 hours after (post-exercise) an exercise training session | |
Secondary | Change in appendicular skeletal muscle mass | Measured by DEXA | Change from baseline to 12 weeks | |
Secondary | Change in whole body fat mass | Measured by DEXA | Change from baseline to 12 weeks | |
Secondary | Change in physical function | Measured by the short performance physical battery | Change from baseline to 12 weeks | |
Secondary | Change in HbA1c | HbA1c concentration | Change from baseline to 12 weeks | |
Secondary | Change in interstitial glucose average | Interstitial average glucose measured via continuous glucose monitoring | Change from 6 hours before (baseline) to 6 hours after (post-exercise) an exercise training session | |
Secondary | Change in interstitial glucose variability | Interstitial glucose variability measured via continuous glucose monitoring | Change from 6 hours before (baseline) to 6 hours after (post-exercise) an exercise training session | |
Secondary | Change in interstitial glucose time in hypoglycaemia | Interstitial glucose time in range (<3.9mmol/L) measured via continuous glucose monitoring | Change from 6 hours before (baseline) to 6 hours after (post-exercise) an exercise training session | |
Secondary | Change in interstitial glucose time in hyperglycaemia | Interstitial glucose time in range (>10mmol/L) measured via continuous glucose monitoring | Change from 6 hours before (baseline) to 6 hours after (post-exercise) an exercise training session |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05653518 -
Artificial Pancreas Technology to Reduce Glycemic Variability and Improve Cardiovascular Health in Type 1 Diabetes
|
N/A | |
Enrolling by invitation |
NCT05515939 -
Evaluating the InPen in Pediatric Type 1 Diabetes
|
||
Completed |
NCT05109520 -
Evaluation of Glycemic Control and Quality of Life in Adults With Type 1 Diabetes During Continuous Glucose Monitoring When Switching to Insulin Glargine 300 U/mL
|
||
Recruiting |
NCT04016987 -
Automated Structured Education Based on an App and AI in Chinese Patients With Type 1 Diabetes
|
N/A | |
Active, not recruiting |
NCT04190368 -
Team Clinic: Virtual Expansion of an Innovative Multi-Disciplinary Care Model for Adolescents and Young Adults With Type 1 Diabetes
|
N/A | |
Recruiting |
NCT05413005 -
Efficacy of Extracorporeal Photopheresis (ECP) in the Treatment of Type 1 Diabetes Mellitus
|
Early Phase 1 | |
Active, not recruiting |
NCT04668612 -
Dual-wave Boluses in Children With Type 1 Diabetes Insulin Boluses in Children With Type 1 Diabetes
|
N/A | |
Recruiting |
NCT05414409 -
The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action
|
Phase 2 | |
Completed |
NCT02837094 -
Enhanced Epidermal Antigen Specific Immunotherapy Trial -1
|
Phase 1 | |
Recruiting |
NCT05670366 -
The Integration of Physical Activity Into the Clinical Decision Process of People With Type 1 Diabetes
|
N/A | |
Active, not recruiting |
NCT05418699 -
Real-life Data From Diabetic Patients on Closed-loop Pumps
|
||
Completed |
NCT04084171 -
Safety of Artificial Pancreas Therapy in Preschoolers, Age 2-6
|
N/A | |
Recruiting |
NCT06144554 -
Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
|
||
Recruiting |
NCT05379686 -
Low-Dose Glucagon and Advanced Hybrid Closed-Loop System for Prevention of Exercise-Induced Hypoglycaemia in People With Type 1 Diabetes
|
N/A | |
Recruiting |
NCT05153070 -
Ciclosporin Followed by Low-dose IL-2 in Patients With Recently Diagnosed Type 1 Diabetes
|
Phase 2 | |
Recruiting |
NCT05281614 -
Immune Effects of Vedolizumab With or Without Anti-TNF Pre-treatment in T1D
|
Early Phase 1 | |
Withdrawn |
NCT04259775 -
Guided User-initiated Insulin Dose Enhancements (GUIDE) to Improve Outcomes for Youth With Type 1 Diabetes
|
N/A | |
Active, not recruiting |
NCT01600924 -
Study on the Assessment of Determinants of Muscle and Bone Strength Abnormalities in Diabetes
|
||
Completed |
NCT02897557 -
Insulet Artificial Pancreas Early Feasibility Study
|
N/A | |
Completed |
NCT02914886 -
Beneficial Effect of Insulin Glulisine by Lipoatrophy and Type 1 Diabetes (LAS)
|
Phase 4 |